Table 1.
COVID-19 patients’ demographic and clinical characteristics
| Social demographic variables | Total cases (n=1113), n (%) | GI symptoms (n=612), n (%) | Non-GI symptoms (n=501), n (%) | P |
|---|---|---|---|---|
| Age | 59.0 (±15.6) | 56.8 (±16.0) | 61.6 (±14.7) | <0.001 |
| Sex | ||||
| Male | 648 (58.2) | 329 (53.7) | 319 (63.7) | 0.001 |
| Smoker/addiction | ||||
| Smoker/addiction | 110 (9.8) | 55 (8.9) | 55 (10.9) | 0.166 |
| Non-GI symptoms | ||||
| Cough | 796 (71.5) | 466 (76.1) | 330 (65.8) | 0.035 |
| Fever | 792 (71.2) | 468 (76.4) | 324 (64.6) | 0.001 |
| Shortness of breath | 653 (58.7) | 352 (57.5) | 301 (60.1) | 0.114 |
| Body pain | 591 (53.1) | 367 (59.9) | 224 (44.7) | 0.001 |
| Decreased appetite | 468 (42.0) | 296 (48.4) | 172 (34.3) | 0.008 |
| Headache | 362 (32.5) | 253 (41.3) | 109 (21.7) | <0.001 |
| Chest pain | 269 (24.2) | 186 (30.3) | 83 (16.5) | <0.001 |
| Sore throat | 186 (16.7) | 131 (21.4) | 55 (10.9) | 0.002 |
| Weight loss | 161 (14.5) | 119 (19.4) | 42 (8.3) | <0.001 |
| Loss of smell | 124 (11.14) | 81 (13.2) | 43 (8.6) | 0.624 |
| Runny nose | 109 (9.7) | 70 (11.4) | 39 (7.7) | 0.431 |
| Sneeze | 79 (7.1) | 55 (8.9) | 24 (4.7) | 0.099 |
| Symptom duration | 8.0 (±6.5) | 7.9 (±5.3) | 8.1 (±7.6) | 0.721 |
| Comorbidities | ||||
| Hypertension | 436 (39.2) | 244 (39.9) | 192 (38.3) | 0.678 |
| Diabetes | 333 (29.9) | 177 (28.9) | 156 (31.1) | 0.417 |
| Ischemic heart diseases | 185 (16.6) | 94 (15.3) | 91 (18.1) | 0.196 |
| Chronic kidney disease | 65 (5.8) | 27 (4.4) | 38 (7.6) | 0.024 |
| Cancers | 35 (3.1) | 18 (2.9) | 17 (3.3) | 0.662 |
| Pulmonary disease | 31 (2.7) | 16 (2.6) | 15 (2.9) | 0.667 |
| Other comorbidity | 256 (23.0) | 139 (22.7) | 117 (23.3) | 0.742 |
GI=Gastrointestinal